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CHAPTER I 
 
 
INTRODUCTION 
Juvenile Rheumatic Diseases: An Overview  
Juvenile Rheumatic Diseases (JRD) are a heterogeneous group of autoimmune 
diseases which are some of the most common in childhood. A meta-analysis of 
practitioner and clinic- based studies found that 132 per 100,000 children were affected 
by juvenile idiopathic arthritis (Oen & Cheang, 1996). Juvenile rheumatoid arthritis 
(JRA) is the most common form of J with an estimated prevalence of between 30,000 and 
50,000 adolescents each year (Lawrence et al., 1998). Other common forms of JRD 
include systemic lupus erythematosus (SLE), juvenile ankylosing spondylitis (JAS), and 
juvenile dermatomyositis (JDMA). Although not typically thought of as a fatal group of 
diseases, JRA has a mortality rate of 0.4% to 2%, which is about three times the rate for 
the general population in the United States (Hashkes, & Laxer, 2008). While JRDs are 
comprised of over 100 different disorders, all include the absence of a known etiology, 
unpredictable pain flare ups, musculoskeletal symptoms and inflammatory issues which 
may lead to physical limitations and medical problems (Nabors, Iobst, Weisman, Precht, 
Chiu, & Brunner, 2007; Minden, 2006).  
JRDs are classified as chronic diseases, which can be defined in multiple ways,
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including Sperry’s (2006) definition as an objective and definable process “marked by 
periods of exacerbation and remission as well as progressive degeneration” (p.6). Chronic 
illness is further defined by Sperry as a subjective experience of a chronic disease. In the 
context of JRDs, most children do not achieve full remission and thus the disease remains 
an ever present burden on the child and family throughout the individual’s lifetime. It has 
been shown that having a child with a chronic disease can impact family cohesion, 
maternal social support, parental mental health, child mental health, and child social and 
academic functioning (Dewey & Crawford, 2007; Frank et al., 1998; Helgeson, Janicki, 
Lerner, & Barbarin, 2003; Sandstrom & Schanberg, 2004). Thus, these children and their 
parents can be considered at risk for potential negative adjustment outcomes.  
The relationship between JRDs and psychosocial adjustment has been widely 
researched. A recent meta-analysis comparing children with JRDs to controls found a 
higher prevalence of internalizing problems in children with JRDs and called for more 
studies looking at specific psychosocial variables that may impact adjustment 
(LeBovidge, Lavigne, Donenberg & Miller, 2003). A high level of support from parents, 
the school system, and peers has been shown to also impact adjustment. Nabors and 
colleagues (2007) found positive family functioning reduced the need for support from 
teachers, classmates and school nurses, however, Von Weiss et al (2002) found high 
levels of support from parents and classmates were related to better adjustment. 
Additionally, high levels of JRD-related pain have been associated with increased 
depressive symptoms (Sandstrom & Schanberg, 2004), negative daily mood (Schanberg 
et al., 2000), worse family functioning, and negative attitude towards their illness (Iobst, 
Nabors, Brunner, & Precht, 2007). The experience of pain and difficulty with physical 
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activity has been shown to impact peer rejection, ability to focus in school and 
involvement in afterschool activities which, in combination, negatively impacts the 
child’s psychosocial functioning at school and self esteem (Degotardi, Revenson, & 
Ilowite, 1999, Sandstrom & Schanberg, 2004).  
In accordance with the transactional stress and coping model, parental distress has 
consistently been shown to be associated with children’s psychosocial adjustment. 
Mothers of children with JRDs report higher levels of depression (Frank et al., 1998), 
decreased quality of life (Bruns, Hilário, Jennings, Silva & Natour, 2008), and increased 
guilt and anxiety (Barlow, Harrison, & Shaw, 1998). Other researchers have found 
normal levels of functioning in the areas of parental distress, family functioning, and 
social support (Gerhardt et al., 2003, Press, Neumann, Uziel, Bolotin, & Buskila, 2002). 
Various studies have shown that while some mothers and fathers exhibit mild distress, 
with scores falling within the normal range of functioning (Frank et al., 1998; Timko et 
al., 1992), it is still important to examine variables which may be impacting negative 
adjustment outcomes. A variety of cognitive appraisals variables, including the construct 
of illness uncertainty, have been linked with psychosocial distress in both parents of 
chronically ill children (Stewart & Mishel, 2000) as well as their children (Mullins et al., 
1997). As such, illness uncertainty will be the primary variable of interest in the current 
thesis.   
 A variety of cognitive appraisal variables linked to JRDs have been studied in the 
past to gain further insight into psychosocial adjustment and psychological distress of 
both children and parents, particularly given that adjustment outcomes have not been 
fully explained by disease presence, course, or severity (e.g., level of pain, physical 
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impairment) (Bruns et al., 2008, Frank et al., 1998, Sawyer, Whitham, Roberton, Taplin, 
& Varni et al., 2004, Vandvik, Hoyeraal, & Fagertun, 1989). Negative attitude towards 
illness has been associated with children reporting a poorer attitude toward their illness, 
less positive illness perceptions and poorer family functioning (Iobst et al., 2007) and a 
positive attitude was a protective factor against the impact of psychosocial stress 
(LeBovidge et al., 2005). Wagner et al. (2003) showed an association between illness 
intrusiveness and child depressive symptomatology, lending further support to the 
transactional stress and coping model of illness. Illness uncertainty is a cognitive 
appraisal variable which has received relatively little attention in the context of JRDs. 
Illness uncertainty has been defined as a cognitive experience elicited in situations in 
which the meaning of illness-related events is unclear and outcomes are unpredictable 
due to a lack of sufficient information or cues (Mishel, 1990). In an analysis of 
uncertainty in childhood illness literature, Stewart & Mishel (2000) identified the most 
commonly reported result of parental uncertainty as psychological distress. Additionally, 
while a small body of research exists on children’s attitude towards juvenile rheumatic 
disease (e.g., Iobst et al., 2007) and illness intrusiveness (e.g., Wagner et al., 2003), only 
one study has examined the role of child illness uncertainty (White et al., 2005). White 
and colleagues found parental distress had a greater impact on child depressive symptoms 
when children exhibited increased levels of perceived illness uncertainty. 
 
The Current Thesis 
 Existing research has yet to examine the association between parental illness 
uncertainty and child illness uncertainty from a transactional perspective in families with 
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JRDs. It is therefore the aim of this study to examine the relationship between parent- 
reported illness uncertainty and child-reported uncertainty in children with JRDs. 
Additionally, the role of parental distress, as measured by the Brief Symptom Inventory 
(BSI), will be examined to see if this variable acts as a moderator between parent and 
child uncertainty. In the sections to follow, a comprehensive review of the literature will 
be conducted. First, an overview of medical and psychological treatment for JRDs will be 
presented. Second, the psychological adjustment difficulties and psychological 
comorbidity of both parents and children with JRDs will be reviewed. Next, information 
regarding cognitive appraisal mechanisms, including illness uncertainty, and their impact 
on both parents of and children who have chronic illness will be covered. Fourth, the 
transactional stress and coping model will be briefly reviewed as a theoretical framework 
to better understand the impact of chronic illness on children and their families. Lastly, 
the current study aims will be presented, including an examination of: 1) the association 
between parental illness uncertainty and child illness uncertainty and 2) the moderating 
role of parental distress in the association of parent illness uncertainty and child illness 
uncertainty. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
Epidemiology of Juvenile Rheumatic Diseases 
All JRDs are characterized by disease onset before a child turns 16, with a peak in 
diagnosis at ages 1-3 and 8-12 years. It is further characterized by persistent arthritis in 
one or more joints for a minimum of six weeks and exclusion of other causes of arthritis 
(Reiter-Purtill, Gerhardt, Vannatta, Passo & Noll, 2003).The most common presentation 
of JRD includes inflammation of the synovial membrane of a joint (synovitis), joint 
stiffness, limitation of motion, pain during motion, joint warmth, gait disturbance, 
fatigue, and vision problems. Although complaints of pain may accompany JRD as it 
does in adult rheumatoid arthritis, children will, at times, not express joint pain 
(arthralgias) upon onset. Thus, joint swelling, stiffness and rash can be important early 
indicators of JRD (McGhee, Burks, Sheckels, & Jarvis, 2002).  
Although the medical etiology of JRDs is not fully understood, genetics, immune 
reactivity, and infectious and environmental factors appear to play a role. Siblings of 
children with JRD are 15 to 30 times more likely than the general population to develop 
JRD (Prahalad, O’Brien, Fraser, Mineau, Pratt, et al., 2004). It is believed that the genetic 
background of the child will also factor into determining the severity of the disease, 
although additional research is called for to determine the exact association (Woo, 2008). 
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Specific genes and proteins (e.g., T cells and S100 proteins in the serum) in the 
body continue to be analyzed in order to determine which may be linked to JRD 
development (Macaubus et al., 2009) though no single microorganism has been identified 
as the cause of JRD. Additionally, many children with JRD have a previous respiratory 
infections, though the exact relationship has yet to be determined (Woo, 2008). The yet 
undetermined etiology of JRDs may play a factor in the illness uncertainty reported by 
parents and children with JRDs (White, Chaney, Mullins, Wagner, Hommel, Andrews & 
Jarvis, 2005). As JRD is a chronic illness, its course varies and is marked by a series of 
flare-ups and remissions which may vary from mild to severely restrictive. The specific 
subtype of JRA, which is identified over approximately the first six months of medical 
care, impacts the presentation and severity of symptoms.  
 Juvenile idiopathic arthritis (JIA) is the most common classification of JRD and 
one of the most common childhood illnesses in the United States. The term JIA is now 
used almost interchangeably with JRDs and is used to describe seven subtypes of JRDs: 
systemic JIA, olioarticular JIA, rheumatoid factor-negative polyarticular JIA, rheumatoid 
factor-positive polyarticular JIA, enthesitis-related arthritis, psoriatic arthritis and 
undifferentiated JIA (Petty, Southwood, Manners, Baum, Glass, Goldberg et al., 2004). 
Although the term JIA is now being used in some of the literature to refer to JRDs, this 
paper will continue in the tradition of using the term “JRD.” 
Systemic-onset juvenile rheumatoid arthritis (JRA) affects one or more joints and 
is preceded by fever for a minimum of 2 weeks lasting for at least 3 consecutive days. 
Systemic-onset JRA is most often diagnosed between the ages of 5 and 10-years-old and 
boys and girls are equally affected. In all cases of systemic-onset, JRA, arthralgia is 
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present. Additionally, the child must exhibit at least one of the following symptoms: 
evanescent erythematous rash, lymph node enlargement, hepatomegaly and serositis. 
Systemic-onset JRA impacts between 2%-17% of children with JRA and is the most 
difficult subtype to treat. The joints of the hands, hips and neck are most commonly 
involved and the child may experience a reduction in dexterity and mobility (Lovell, 
2008; Rapoff, Lindsley, Karlson, 2009). 
 Oligoarticular (Pauciarticular) JRA (oJRA) affects one to four joints during the 
first six months, usually the knees or ankles. Arthritis must be present for six weeks in 
order to make a diagnosis. This subtype occurs in 24-58% of children with JRA. oJRA 
has two subtypes which are categorized by the total number of joints affected over the 
lifespan of the disease. Persistent oligoarthritis affects no more than four joints total. 
Extended oligoarthritis affects more than four joints after the first six months of the 
disease. Within these subgroups, two gender distinctions can be made in regards to other 
possible complications. Some younger females may test positive for antinuclear 
antibodies (ANA) and thus have a risk of developing eye problems (uveitis) which occur 
in 30-50% of those with oJRA. Some older boys will have a long-term risk of arthritis in 
the axial skeleton, hips and back (Lovell, 2008; Rapoff et al., 2009). 
Polyarticular JRA (pJRA) involves five or more joints during the first six months 
and occurs in about 12-40% of cases. It is more common in females than males (Lovell, 
2008). The joints in the neck, hands, wrists, hips, knees and ankles are most commonly 
affected by synovitis. Weight loss, anemia, growth retardation and low-grade fever may 
be present. While the disease can begin at any age, if it begins when a child is very young 
his or her mandibular growth center may be impacted resulting in facial asymmetry. A 
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positive rheumatoid factor may designate a more serious course of the disease (Rapoff et 
al., 2009).  
 Systemic lupus erthematosus (SLE) presents in children as fever, rash, fatigue, 
weight loss, arthralgias and synovitis (Kaufman, 1986). Females are affected at four 
times the rate of males and ethnic minorities also have higher prevalence rates (White, 
1993). Genetic predisposition, viral infection and a poor immune system interact to cause 
SLE though no primary cause is known (Kaufman, 1986). SLE is characterized by 
autoantibodies which attack self-antigens and result in synovitis, inflammation of organs, 
blood vessel abnormalities and immune system dysregulation. Increased production of 
ANA results in immune complex formation and tissue damage. Hematologic 
abnormalities such as thrombocytonpenia, leucopenia, lymohocytopenia, and hemolytic 
anemia may occur. In the past thirty years, the outcome prognosis and survival rates of 
SLE have drastically improved because of earlier recognition and more advanced 
treatment methods and medications (González, Hernández, Olguín, Miranda, Lira, Toso, 
et al., 2005). 
 
Medical Treatment of JRDs 
 Aspirin is the most consistently used anti-inflammatory drug to initially treat 
JRDs, primarily due to its’ ease of administration, availability, and low cost. However, 
the need to administer aspirin three times per day, the possible influence on serum 
transaminases levels and other liver function tests,  and association with Reye syndrome 
have made it less popular. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often 
used in treatment with Naproxen or ibuprofen as the first choice with young children. 
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Adolescents often use oral, once-a-day NSAIDs such as nambutome, prioxicam or 
celicoxib. Approximately 50% of patients show symptom relief within the first two 
weeks and the remainder during the first eight weeks of use (Jordan & McDonagh, 2006). 
NSAIDs should continue to be used 12 to 18 months after symptoms have disappeared, 
which can result in considerable problems with adherence during this time. 
Approximately 25%-33% of children with JIA, usually those with oJIA, respond well to 
NSAIDs (Hashikes & Laxer, 2005). As NSAIDs do not directly modify the disease, they 
are mainly used to treat pain, joint stiffness and fever. A possible side effect of NSAIDs 
is gastrointestinal (GI) distress, which may also lead to adherence problems. However, GI 
distress can usually be avoided by administration of medication with food.  
If a child is unresponsive or minimally responsive to NSAIDs, disease-modifying 
anti-rheumatic drugs (DMARDs) are used (Hashkes & Laxker, 2008). Methotrexate 
(MTX) is a common DMARD that acts by inhibiting the metabolism of folic acid. MTX 
use is discontinued when possible because of many associated side effects, including 
anemia, neutropenia, increased risk of bruising, nausea, dermatitis and diarrhea (Jordan & 
McDonagh, 2006). A meta-analysis by Hashkes and Laxer (2005) found MTX to be most 
widely used with children who have polyarthritis, most effective with oJIA, and 
ineffective with systemic JIA. While NSAIDs should be administered with food, MTX 
should be given on an empty stomach as food decreases its bioavailability. High dosage 
treatments (above 12mg/m2) should be administered intravenously. To decrease 
associated nausea, ulcers in the mouth and liver enzyme abnormalities, folic acid should 
be given orally 24 hours after administration. Nausea and GI side effects are common but 
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can be dampened by MTX administration before bedtime, intravenous (versus oral) 
administration, and using antiemetics (Hashkes & Laxker, 2008).  
Intra-articular (IA) corticoseteroid injections may be used short-term during the 
beginning of treatment as DMARDs may not be effective for many months. 
Corticosteroids are long-acting steroids that result in increased mobility and decreased 
pain and stiffness. Although IA corticosteroids provide quick relief to the child, they 
must be administered in a doctor’s office and multi-injection visits often necessitate 
sedation for younger children. The most common sedatives are Ketalar or Propofol and 
these may be paired with Fentanyl to reduce associated pain (Padeh & Passwell, 1998). 
Triamcinolone hexacertonide is administered intra-articularlly and dosage varies by 
severity of inflammation and size of joint. Corticosteroids can be administered orally or 
intravenously for higher doses, which have been especially effective for children with 
oJIA. Padeh & Passwell (1998) reported that 82% of treated children had a full remission 
of synovitis, with remission lasting more than 6 months post injection. These children 
also evidenced decreased pain and increased movement, and 40% were arthritis-free in 
that joint for over two years. Intra-articular injections beginning soon after diagnosis of 
oJIA have been shown to reduce leg length discrepancies which may lead to improved 
movement over time (Hashkes & Laxer, 2005).  
Prednisone doses of 1 mg daily have also proven successful for treating SLE 
(Kaufman, 1986). While beneficial, use of IA corticosteroids should be avoided if 
possible because of serious side effects including toxicity, acne, cataracts, growth 
retardation, Cushings disease, osteoporosis, fractures, obesity and hypertension 
(Kaufman, 1986; Rapoff et al., 2009). Additionally, patients with SLE who have received 
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doses over 20 mg/day have developed a cushingoid appearance including bloated faces, 
weight gain, easy bruising, and abdominal, breast, thigh and upper arm striae which 
disappear with reduced dosage (Kaufman, 1986). 
 Anterior uveitis, a type of eye disease that causes swelling and pain in the middle 
portion of the eye, occurs in between 5% to 50% of children with JRA and can include 
problems with cataracts, glaucoma and band keratopathy. Risk factors for uveitis include 
diagnosis prior to age six, oJIA, and ANA positivity (Lindsley, 2005). Girls under the age 
of 8 with positive ANA and oJIA are at the greatest risk (Jordan & McDonagh, 2006). 
Anterior uveitis is assessed by an ophthalmologist using a slit lamp examination and can 
be treated with topical Methotrexate drops. If drops are not initially effective, subtenon 
corticosteroid injections may be implemented in the treatment plan. School performance 
should be monitored as uveitis can cause difficulties in seeing classroom boards and 
focusing on reading in textbooks.    
Children with JRAs may have growth abnormalities related to poor nutritional 
status and low muscle mass. NSAIDs and MTX can cause loss of appetite whereas 
corticosteroid may lead to weight gain, hypertention, bone loss and calcium and vitamin 
D deficiencies. Thus nutrition, protein and weight should be monitored during clinic 
visits and nutritional supplements may be used as a part of treatment (Hashkes & Laxer, 
2008; Lindsley, 2009).  
Physical therapy is a central aspect in treatment of JRDs and assists in controlling 
pain, improving range of motion and muscle strength, preventing limb deformities and 
minimizing or preventing loss of functioning, and ensuring normal growth and 
development (Cakmak & Bolukbas, 2005). Children with JRDs often hold their joints in 
13 
 
positions that are most comfortable for them, and often do not initiate enough movement. 
Subsequently, they develop weakness and compensatory contractures around inflamed 
joints. Physical therapy includes guided range of motion and strengthening exercises, 
splints, serial casting as well as positioning to steady joints and straighten joint 
deformities (Akikusa & Allen, 2002). Heat treatment, cold treatment, massage and 
therapeutic exercises can be delivered in therapy but must also be implemented in home-
based programs. When used on the knees and feet, these methods can improve gait, 
decrease pain while walking, and minimize pressure to reduce calluses. Occupational 
therapy for the wrists, hand and fingers can aid in improving efficiency at daily activities 
such as eating, writing and washing. Although primarily used with children who have 
JIA, physical therapy is also used with juvenile dermatomyositis, scleroderma and SLE. 
Parents often allow, and at times encourage, children to avoid physical activity, 
especially if it is paired with pain complaints (Gerhardt et al., 2003). Exercise should be 
encouraged as it has been shown to decrease joint symptoms and improve affect. Klepper 
(1999) found a decrease in an articular severity index and joint count and an increase in 
aerobic endurance after an 8-week weight-bearing, physical conditioning program.  
  Chronic pain is a hallmark characteristic of arthritis, though the majority of young 
children report little or no pain. However, for those children who do experience 
significant pain, a decrease in quality of life is often observed (Sawyer, Whitham, 
Roberton, Taplin, Varni, & Baghurst, 2004). Pain is often a result of the heat caused by 
the rubbing of joint fibers during synovitis and continues due to sensitization in affected 
joints. It is important to have an accurate understanding of the child’s pain experience, as 
pain has been linked to increased anxiety, depressive symptoms, negative mood, 
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emotional distress, poorer attitude about illness, decrease in quality of school work, and 
difficulty concentrating in school (Iobst et al., 2007; Nabors et al., 2007; Rapoff et al., 
2009; Sandstrom & Schanberg, 2004). Additionally, pain has been associated with 
externalizing behaviors, malpositioning of affected joints, and avoidance of physical and 
social activities. Such behaviors have been shown to be maladaptive and should be 
discouraged by parents through reinforcement of positive coping strategies and 
enforcement of rules such as school attendance and physical therapy exercise adherence 
(reference here). When conducting psychosocial interventions including pain 
management, the "gate-control theory" can be used to conceptualize the sensory, affective 
and evaluative components of the pain experience and how they may possibly influence 
disease activity (Smith & Dalen, 2007). As poor coping skills have been associated with 
higher levels of pain, pain coping strategies should be taught during therapy and should 
continue to be assessed using tools such as the Pain Coping Questionnaire (Reid, Gilbert, 
McGrath, 1998). Cognitive refocusing on activities which distract the child from pain and 
a posttraumatic growth perspective have both been shown to be superior to emotion-
focused avoidance (catastrophizing) and cognitive self instruction (wishful thinking) 
(Rapoff, Lindsley, & Karlson, 2009; Smith & Dalen, 2007). Additionally, cognitive 
behavioral techniques such as progressive muscle relaxation, guided imagery, and 
meditative breathing have been shown to be helpful when pain impacts academic 
performance, extracurricular participation and interpersonal interactions (Walco, Varni, 
& Ilowite, 1992). 
Psychological Treatment of JRD-Associated Problems 
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 In the following section, the research regarding the psychological treatment of 
children with a chronic illness will be briefly reviewed. Psychological treatment has been 
shown to be successful in multiple domains.  Treatment options will be discussed in the 
following order: treatment adherence, self-care behaviors, and parenting strategies and 
support.  
Treatment adherence is a significant problem across multiple chronic illness 
groups, with research demonstrating decreases in adherence occurring with the duration 
of the illness (Rapoff, 1999). It is therefore important to educate families about the nature 
of their treatment regimen early after diagnosis. In the context of the Health Belief 
Model, education about the short and long-term benefits of following a treatment regimen 
has been shown to improve adherence (Rosenstock, Strecher, & Becker, 1988). 
Decreasing uncertainty about disease management and course begins with the pediatric 
rheumatologist educating parents and children during doctors visits. Akikusa & Allen 
(2002) recommend four steps to improving education about JRDs: a separate educational 
session, exploration of patient/family beliefs and misconceptions about JRDs, selection of 
the least complex treatment regimen, and careful discussion about medications. Although 
education has been shown to be effective, Rapoff (1999) found a combination of 
education and behavioral strategies produce the highest levels of compliance. 
Additionally, he found a clinic-based, nurse-administered behavioral and educational 
program prevented a drop in adherence over time to nonsteroidal anti-inflammatory 
medications in children with JRDs (Rapoff, Belmont, Lindsley, Olson, Morris, & Padur, 
2002).The inclusion of a psychological component in addition to education (e.g., 
relaxation, biofeedback, cognitive-behavioral therapy) was supported in a meta-analysis 
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of 25 studies with rheumatoid arthritis patients. Significant improvements in coping, pain, 
functional disability, depression and self-efficacy were found, with improvements 
remaining in coping, tender joints and depression at an 8.5 month follow-up (Astin, 
Beckner, Soeken, Hochberg, & Berman, 2002).   
Self-care behaviors have been linked to family functioning, the psychological 
health of parents and children, and coping strategies utilized. In order to assure optimal 
treatment adherence, teaching coping skills and thereby enhancing psychological 
adjustment should be considered. Moos (2002) posited a general stress and coping 
framework that can be used to understand the adaptation of adolescents with chronic 
illnesses. He posited a transactional chronic illness model that mapped reciprocal 
feedback among the context of the illness, the adolescent’s coping, and the adolescent’s 
adaptation. Moos stated it is important to study the process of both coping and crisis 
resolution, as well as the link between parent and child coping behavior and parental 
resources and child adjustment. Maladaptive coping skills have been routinely associated 
with poorer psychological and physical health. Specifically, catastophizing has been 
related to increased pain, functional disability and depression in those with rheumatoid 
arthritis (Keefe, Brown, Wallston & Caldwell, 1989) and avoidance coping has been 
associated with impulsive outbursts and adjustment problems in children with JRDs 
(Degotardi et al., 1999).  While the effectiveness of coping strategies depends on the 
child’s cognitive-developmental and situation, approach coping skills have been shown to 
be the most beneficial overall (Thompson & Gustafson, 1997). Approach coping skills 
center around seeking information rather than avoiding information, and have been 
associated with less distress in relation to stressful medical procedures (Blout, Davis, 
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Powers & Roberts, 1991). Coping skills education is especially important as youth with 
JRDs have been found to use a wider variety of coping skills than control youth (Harris, 
Newcomb & Gewanter, 1991). 
 Parental treatment regimen and emotional support of children with chronic illness 
has been shown to be beneficial for both the ill child and the parents. In a study by Berg 
and colleagues (2007), collaborative coping, or the teamwork approach, was associated 
with less depressive symptoms and more positive emotion in children with type 1 
diabetes and their mothers. Collaborative coping included appraising each other as being 
actively involved in brainstorming and negotiating about stressful events related to the 
illness. While parents of children with chronic illness have been shown to be more hands 
on, the greatest benefits have been seen when a balance is achieved through collaborative 
disease management and the sharing of control.  
When parents feel they have mastery over their child’s disease, they exhibit more 
positive, supportive parenting. Children with JRDs reported less distress and more social 
integration when their mothers had a sense of mastery (Timko, Stovel, Moos, & Miller, 
1992). Similar results have been found in families of children with epilepsy. Increased 
parental encouragement of child autonomy and parental support are associated with 
decreases in behavior problems (Austin, Dunn, Johnson, & Perkins, 2004) and 
internalizing problems (Sbarra, Rimm-Kaufman, & Pianta, 2002). Parental control may 
be beneficial in its emphasis on disease management but too much control may also 
reduce expressiveness and independence (Moos, 2002). In a recent literature review of 
family factors and psychopathology, the authors opined that overprotectiveness itself may 
not be a negative parenting factor, but that its level should be appropriate with the 
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developmental stage of the child (Rodenburg, Meijer, Deković & Aldenkemp, 2005). 
Further, the support of parents and siblings has been shown to reduce both internalizing 
and externalizing behavior problems in children with JRA (Timko, et al., 1995, Varni, 
Wilcox, & Hanson, 1988). Adjustment to JRDs, including less illness worry, less 
appearance worry, and higher self-esteem, can be improved by reducing family conflict 
and increasing family cohesion through communication (Helgeson, Janicki, Lerner, and 
Barbarin, 2003). Additionally, support from friends, teachers and peers is associated with 
fewer adjustment problems, depressive symptoms (von Weiss et al., 2002), lower 
psychological distress and higher self-esteem (Varni, Katz, Colegrove, & Dolgin, 1994, 
Varni, & Setoguchi, 1996).  
Psychological Comorbidity 
Parent Adjustment.  Children are not the only individuals affected by their chronic 
illness; the transactional stress and coping model posits parent’s psychosocial health is 
also influenced by their children’s chronic illness. The major aim of past research has 
been to document parental adaptation; however, more research now includes the manner 
in which parental attitudes, psychological distress and functioning influence child 
adjustment (Kazak, Rourke, & Navsaria, 2009; White et al., 2005). As it has been shown 
that parental adjustment and family system variables have more predictive power 
regarding child adaptation and adjustment than disease factors or illness severity, it is 
critical to continue to look at variables influencing parental adjustment (Cohen, 1999; 
Frank et al., 1998).  
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In general, parents of chronically ill children have reported greater use of 
psychological services (Cadman, Rosenbaum, Boyle, & Offord, 1991), more depression 
(Frank et al., 1998), greater stress, and less martial satisfaction (Katz, 2002) than those of 
healthy children. In a survey of 1,800 families, Cadman and colleagues (1991) found 
mental health treatment was 2-3 times more commonly utilized by parents of chronically 
ill children than by parents of healthy children. Utilization of health services not only 
takes time away from self-care, care of family and employment obligations but it takes a 
monetary toll on families who are already carrying additional medical expenses related to 
the JRD. Risk factors for parent’s psychological distress include daily hassles stress 
(Manuel, 2001), higher levels of physical limitations (Lustig, Ireys, Sills & Walsh, 1996), 
child behavior problems (Frank et al., 1998), social impairment, and perceived higher 
level of distress and burden (Mullick, Nahar, & Naq, 2005).  
Parents of children with juvenile rheumatoid arthritis and juvenile diabetes report 
higher levels of depressive symptoms, compared to parents of control children, which 
have been linked with increased burden of care, loss of social activities and their own 
physical health problems (Frank et al., 1998). Wallander (1993) found that mothers of 
children with sickle cell disease frequently met criteria for major depressive disorder 
(21%), and other affective disorders, with 34% meeting criteria for at least two disorders. 
Parental distress has been found to be related to distress in children with cancer 
(Robinson, Gerdardt, Vannatta, & Noll, 2007), spina bifida (Friedman, Holmbeck, 
Jandasek, Zuckerman, & Abad, 2004), and juvenile rheumatic disease (Timko et al., 
1992). In further support of the transactional nature of chronic illness, the presence of 
parental psychological distress has been linked with child adjustment problems.   
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 The experiences of families are not always maladaptive, and some researchers 
have demonstrated that functioning of JRD families may similar to control families in 
terms of  quality of life (Press et al., 2002), parental distress, family functioning, social 
support (Gerhardt et al., 2003), and perceived competence (Harris, Newcomb, & 
Gewanter, 1991). Family cohesiveness (Dewey & Crawford, 2007), cooperation, 
participation of family members in caring for the chronically ill child (Katz, 2002), 
positive maternal appraisal of the illness, high level of maternal education (Manuel, 
2001), a sense of maternal mastery about the illness, and more social integration (Timko, 
Stovel, Moos, & Miller, 1992) have been associated with better parental and family 
functioning. It is thus important to examine variables which predict adjustment of 
specific family members as well as specific characteristics of varibles which may act as 
either risk or resistance variables.  
 Child Adjustment. In general, children with a chronic illness have a risk for 
adjustment problems that is 1.5 to 3 times higher than their healthy peers (Pless, 1984). A 
meta-analysis looking at the psychological adjustment of children and adolescents with 
chronic arthritis by LeBovidge and colleagues (2003) showed they were at a 13% to 45% 
increased risk for internalizing symptoms compared to controls. In another study of 
individuals with JRA, 21% of the children with JRA were clinically depressed, with the 
level of depression and anxiety increasing with the degree of disability (David, Cooper, 
Hickey, Lloyd, Dore, McCullough, et al., 1994). Children with juvenile rheumatic disease 
have been shown to have higher rates of depression when they experience pain, peer 
rejection and problematic social behavior (Sandstrom & Schanberg, 2004). As such, 
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social support and school adjustment can be key factors in child psychosocial 
functioning.  
A child who has JRD can have serious impairment in the amount of classroom 
activities in which they are able to participate. Gym class activity and after-school sports 
can be impacted by joint pain, stiffness and growth retardation.  When a child with a JRD 
is able to participate in physical activity, he or she has more difficulty participating and 
may not feel adults within the school make accommodations to allow for their full 
participation (Nabors et al., 2007).  
  Compounding the negative influence of physical difficulty in participation is the 
possible dissatisfaction with physical appearance caused by leg braces and swollen joints. 
The decrease in participation with peers during activity can separate children with JRDs 
from their healthy peers and negatively impact the amount of social support felt from 
other school children during a time that is already ripe with difficulties related to self 
confidence and self-esteem (Degotardi et al., 1999). Additionally, the chronic pain has 
been shown to impede the child’s ability to focus in school and influence the quality of 
their school work. Von Weiss et al. (2002) reported that children with JIA who had more 
support from classmates and parents were better adjusted than those without high levels.   
  Social support is fostered through good peer relationships, which can only occur 
with the allowance of autonomy from the parents. It has been shown that parents of 
chronically ill children may unknowingly discourage autonomy by being overprotective 
and overly directive (e.g., Power, Dahlquist, Thompson, & Warren, 2003; Thomasgaard, 
Shonkoff, Metz, & Edelbrock, 1995). Mothers exhibited increased worry about general 
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health and joint injury, specifically, and did not allow them to play more physically 
rigorous games whereas fathers reported increased difficulty punishing their children who 
had a JRD (Gerhardt, Vannatta, McKellop, Taylor, Passo et al., 2003). Parents may 
generalize their child’s need for assistance with JRD related activities to other areas of his 
or her life including, for example, cognitive tasks that are not going to be influenced by 
the physical difficulties of JRDs (Power et al., 2003). Psychosocial functioning is 
improved when children with JRDs are supported yet given a developmentally 
appropriate level of autonomy.  
         In summary, psychosocial functioning of chronically ill children and their family 
members can be impacted by the presence of a chronic illness. However, psychosocial 
functioning and illness course and severity are not the only predictors of parental and 
child adjustment. Research has also indicated that cognitive appraisal variables are 
consistent and sometimes robust predictors of adjustment across chronic illnesses.  
Illness Uncertainty 
The role of cognitive appraisal variables has been examined across child chronic 
illnesses, yet much work needs to be done in order to fully understand their impact on the 
experiences of both parents and children. One such variable that has received 
considerable attention is that of illness uncertainty (e.g., Hommel, Chaney, Wagner, 
White, Hoff, & Mullins, 2003; Mullins, et al., 1997; White et al., 2005). Illness 
uncertainty has been defined as a cognitive experience elicited in situations in which the 
meaning of illness-related events is unclear and outcomes are unpredictable due to a lack 
of sufficient information or cues (Mishel, 1990). Mishel posited that illness uncertainty is 
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comprised of four components: perceived ambiguity regarding the state of the illness, 
complexity regarding treatment, lack of information about the seriousness of the illness 
and prognosis, and perceived unpredictability of the illness course (Mishel, 1984). 
Additionally, she stated that stress and uncertainty are related not through the appraisal of 
an event as stressful but by the vagueness, lack of clarity and lack of information 
surrounding the event. JRDs are certainly appropriate to examine in the context of illness 
uncertainty, as they are characterized by a highly variable and unpredictable illness 
course (Akikusa & Allen, 2002, Jordan & McDonagh, 2006). 
Cognitive attributions, including illness uncertainty, have been shown to be 
salient variables when aspects of an illness are ambiguous or variable. Mullins and 
colleagues examined the role of illness uncertainty and causal attributions in older 
adolescents and young adults with asthma and found both increased illness uncertainty 
and increased stable attributions for negative events were associated with poorer 
psychological health ((Mullins, Chaney, Balderson & Hommel, 2000, Mullins, Chaney, 
Pace, & Hartman, 1997). Similar findings were shown in individuals with multiple 
sclerosis (Mullins, Cote, Fuemmeler, Jean, Beatty, & Paul, 2001). In another study with 
older adolescents with asthma, illness uncertainty was again associated with anxiety and 
but not with depression (Hommel, et al., 2003).  In an analysis of uncertainty in 
childhood illness literature, Stewart & Mishel (2000) identified the most commonly 
reported consequence of heightened parental uncertainty was psychological distress. 
When looking at longitudinal psychological distress in parents of chronically ill children, 
general distress can be predicted by initial illness uncertainty above and beyond the 
variance attributed to child illness duration and initial psychological distress in parents of 
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children with type 1 diabetes mellitus (Carpentier et al., 2006). Illness uncertainty thus 
continues to be an important factor to consider when analyzing cognitive appraisal 
variables in order to fully understand the course of parent and caregiver mental health. 
Additionally, it has been shown that a reduction in illness uncertainty has been linked to 
better mental health outcomes. By examining illness uncertainty in the initial stages of 
treatment and identifying methods to reduce this cognitive attribution, a preventative 
approach to care can be utilized.  
In addition to the impact of illness uncertainty on parents and caregivers, 
psychological distress has been shown to be associated with increased illness uncertainty 
in children with chronic illness. In a study by Neville (1998), 30% of the total variance in 
psychological distress of children with cancer could be predicted by uncertainty. Distress 
has also been seen in youth with asthma (Mullins et al., 1997), type 1 diabetes (Hoff, 
Mullins, Chaney, Hartman, & Domek, 2002) and JRDs (White et al., 2005). To date, 
research has failed to adequately incorporate illness uncertainty into the transactional 
model and to study its impact on multiple family members. White and colleagues (2005) 
found parental distress had a greater impact on child depressive symptoms when children 
exhibited increased illness uncertainty. Additionally, they found there was a significant 
interaction effect of high child illness uncertainty and parental distress on child 
depression scores. However, they did not find an interaction effect when child illness 
uncertainty scores were low. To build on the research of White and colleagues, the 
relationship of parental illness uncertainty on the illness uncertainty experienced by 
children with JRDs needs to be explored. Additionally, there has been no research that 
looks at the direct effect of parental illness uncertainty on child illness uncertainty in the 
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JRD population. To build on the existing research on illness uncertainty, examination of 
this link in this disease specific population will be completed. To better place the current 
research in context, the Transactional Stress and Coping Model will be briefly reviewed.   
Transactional Stress and Coping Model 
The transactional stress and coping model (TSC; Thompson, Gustafson,Hamlett, 
& Spock, 1992) conceptualizes chronic illnesses as stressors within an ecological-
systems-theory perspective (Bronfrenbrenner, 1977). The interaction of illness and 
parental adaptational processes, including methods of coping, stress processing, and 
family functioning, is related to the health status and psychological well being of the 
child In this model, chronic illness is viewed as a potential stressor, and the family 
system subsequently responds to the stressor in adaptive or maladaptive ways. The 
ecological-systems-theory provides the basis for inclusion of demographic factors (child 
gender and age, family SES), illness parameters (type and severity),  and both child and 
family functioning in the TSC model. 
Within the TSC model, child and parent adaptational processes are viewed as both 
separate and, yet ultimately, interacting. Three types of psychosocial mediational 
processes are outlined for mother’s adaptation: 1) cognitive appraisal-stress surrounding 
daily hassles and illness tasks, expectations of efficacy and health locus of control; 2) 
coping methods (palliative or adaptive); and 3) family functioning (supportive, conflicted 
or controlling). Child psychosocial mediational processes are expectations of self-esteem, 
health locus of control, and methods of coping (Thompson & Gustafson, 1994).  
The model has been used by Thompson and numerous other researchers to study 
the link between parent and child adjustment in a wide variety of chronic diseases (e.g., 
26 
 
Carpentier, et al.; Frank et al., 1998). Cognitive appraisals by both the parents and child 
have been shown to influence levels of distress and adjustment in both individual and 
family functioning. In families with children who have juvenile rheumatic arthritis, 
family conflict has been found to be related to greater adjustment difficulties, whereas 
family cohesion (supportive functioning) has been associated with fewer adjustment 
difficulties (Helgeson, Janicki, Lerner &Berberin, 2003). Even when controlling for 
disease factors, family and social support continued to be a significant predictor of 
psychological adjustment in children with JRA, per maternal report (Varni, Wilcox, & 
Hanson, 1988). Furthermore, Dewey and Crawford (2007) found higher levels of both 
maternal and paternal psychological distress were associated with lower family cohesion.  
A parent’s psychological functioning is often impacted by the reality that their 
child is living a different life than they had pictured, a phenomenon sometimes referred to 
as “chronic sorrow” (Kokkonen, Kokkonen, & Moilanen, 2001). Parents are attuned to 
their child’s interpersonal and psychological difficulties and can feel overwhelmed by 
their own expectations about their effectiveness in helping their children cope and 
managing their child’s illness. Higher levels of maternal reported stress have been 
associated with poorer child adjustment when factoring out illness and demographic 
parameters (e.g., Thompson, Gil, Keith, Gustafson, George, & Kinney, 1994). In the 
context of JRDs, Wagner and colleagues (2003) demonstrated that both parental distress 
and illness intrusiveness impacted child depression. Additionally, they found that 
children’s perceptions of illness intrusiveness were significant predictors of child 
depressive symptomatology.  Thus, the TSC model certainly appears to be a model 
relevant to the experience of families of a child with a JRD. 
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When examining the possible relationship of child uncertainty to child distress, it 
is appropriate to do so from a transactional stress and coping model framework. Previous 
research has evaluated the influence of cognitive appraisals, including illness uncertainty, 
on children who have a chronic illness (Andrews, Chaney, Mullins, Wagner, Hommel, & 
Jarvis, 2007; Carpentier et al., 2007; Mullins, et al., 2007). Mullins and colleagues (2007) 
viewed illness uncertainty as a person-environment interaction between the objective 
experience of chronic illness and an individual’s cognitive appraisal of their subjective 
experience of the events. Previous studies have shown illness uncertainty to be connected 
with parental and child adjustment to cancer (Grootenhuis & Last, 1997), asthma 
(Mullins, et al., 1997; Van Pelt, Mullins, Carpentier, & Wolf-Christensen, 2006) and 
Type 1 Diabetes (Carpentier, Mullins, Chaney, & Wagner, 2006). In the present study, 
the impact of parental distress on both parental and child illness uncertainty will be 
examined in order to better understand the relationship of parental uncertainty to child 
uncertainty in the context of pediatric rheumatic disease. 
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CHAPTER III 
 
 
METHODOLOGY 
Participants and Procedure 
 Participants were 61 (41 females; 20 males) children and adolescents between the 
ages of nine and 21 (M = 14.42; SD = 2.88), who had been diagnosed with juvenile 
rheumatoid arthritis (JRA; N = 35), systemic lupus erythematosus (SLE; N = 14), 
juvenile ankylosing spondylitis (JAS; N = 4), and juvenile dermatomyositis (JDMA; N = 
7), and their parents. The majority of child participants were Caucasian (45.9%), 
followed by Native American (26.2%), African American (9.8%), Hispanic (9.8%), 
Biracial (6.6%), and Asian (1.6%) (See Table 1 for complete descriptive statistics). 
Participants were recruited from a pediatric rheumatology clinic in the Southwestern 
United States.  Institutional Review Board approval was granted and written informed 
assent and consent were obtained from each participant, parent or legal guardian. 
Inclusion criteria for eligibility included the following: 1) diagnosis of JRA, SLE, JAS or 
JDMA, 2) between the ages of 9 and 21, 3) no other comorbid cognitive deficits or 
chronic illness, and 4) duration of symptoms for at least one year.  Participants met 
illness duration criteria if they had active symptoms for at least one year, therefore some 
participants were included who did not have a formal diagnosis for one full year. Illness 
duration was calculated by subtracting the date of diagnosis from the date of data 
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collection 0.04 years to 15.73 years (M = 2.57; SD = 3.24). Inclusionary criteria were 
verified through rheumatologist and self report.  Each participant family was 
compensated monetarily with $10.00.   
 Eligible participants were identified by the rheumatologist and then contacted by 
a research assistant. While the majority of participants were recruited in the clinic, those 
who were not scheduled for upcoming appointments were contacted via telephone. 
Packets for the study were disseminated during a clinic visit or were sent to the family in 
the mail. The packets were either completed in the clinic or sent back to the research 
assistant in a pre-paid postage envelope.  Study packets included a background 
information questionnaire, a parental consent form, a child assent form, a BSI for the 
parent to complete, and a JAFAR-C, CDI, and CUIS for the child to complete. As this 
study was part of a larger study, other psychosocial measures were included in the packet 
that will not be covered in the scope of this manuscript. Participant families were $10 in 
monetary compensation once their completed packet was received.  
 
Measures  
Physician-Report Measures 
Provider Questionnaire. The provider questionnaire was completed by the 
rheumatologist once the researchers had received a completed packet. It included 
information about diagnosis (type, date), current medications, disease severity and 
functional class. Disease severity was assessed using a 7-point Likert scale, ranging from 
1 (disease not active or in remission) to 7 (severe). The Steinbrocker revised criteria for 
the classification of global functional status in rheumatoid arthritis was used to assess for 
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functional disability. Research has shown the criteria to be a valid measurement for this 
population (Adib, Silman, Thompson, 2005; Hochberg et al., 1992).  Patients were 
categorized into one of four classes, wherein Class I denoted no disruption in ability to 
perform daily activities and Class IV denoted limitations in ability to perform usual daily 
self-care, vocational and avocational activities (Hochberg et al., 1992).  Data collection 
was previously completed as part of a larger research project on JRDs conducted at 
OUHSC, as such, variables not pertinent to the current research study were not included 
in this manuscript.   
Parent-Report Measures 
Background Information Questionnaire.  The questionnaire was used to gather 
information about age, gender, ethnicity, and other demographic variables. The present 
study will only utilize the data about age, gender, and ethnicity. 
 Brief Symptom Inventory. (BSI; Derogatis & Melisaratos, 1983). The parents 
completed the BSI, a 53-item questionnaire used to assess global psychological 
functioning in nine domains (e.g., somatization, depression). Respondents rate the degree 
of their distress over the past 7 days using a Likert scale, ranging from 0 (not a lot) to 4 
(extremely). The global severity index (GSI) and the Depression scale will be looked at to 
determine level of distress.  It has been used in previous studies with the pediatric chronic 
illness population (Andrews et al., 2007; Canning, Harris, & Kelleher, 1996; Pai et al., 
2006; Wagner et al., 2003; White et al., 2005) and has been shown to have good internal 
consistency with alpha coefficients ranging from 0.71 to 0.85 (Derogatis & Melisaratos, 
1983) Cronbach’s alpha for the present sample was found to be high (α=.96).  
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Mishel Uncertainty in Illness Scale – Community Form. (MUIS-C, Mishel & 
Braden, 1988). The MUIS-C is a 23-item questionnaire which assesses the four 
components of illness uncertainty: ambiguity, uncertainty, lack of information, and 
unpredictability. Respondents rate their illness uncertainty on a 5-point Likert scale 
ranging from 1 (very true) to 5 (very false). A total sum score is calculated with higher 
scores reflecting greater illness uncertainty. The MUIS-C has been used with chronic 
illness populations in the past (e.g., Carpentier et al., 2007; Van Pelt et al., 2006) and 
reliability coefficients for the MUIS-C have been high, ranging from .74 to .92 (Mishel, 
1997).  Cronbach’s alpha for this sample was also found to be high (α=.88).  
Child- Report Measures 
Children’s Uncertainty in Illness Scale (CUIS; Mullins & Hartman, 1995). The 
CUIS is a 23-item self-report measure used to address four components of children’s 
perceived uncertainty regarding their illness: ambiguity, lack of clarity, lack of 
information, and unpredictability. The items included in this version have been adapted 
from the Mishel’s (1983) original Uncertainty in Illness Scale – Community Form adult 
version in order to be developmentally appropriate. Participants rate items (e.g., “My 
treatment is hard for me”) on a 1-5 Likert scale, ranging from 1 (very true) to 5 (very 
false). A total sum score is calculated with higher scores reflecting greater illness 
uncertainty. The CUIS has good internal consistency reliabilities, with alphas ranging 
from 0.88 to 0.89, and has been used with pediatric chronic illness populations in the 
past). Chronbach’s alpha for the present sample was also found to be high (α=.85).  
Statement of Purpose 
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Based on the preceding literature review, it appears that children with JRDs are at 
an increased risk for negative psychological adjustment outcomes (David et al., 1994; 
LeBovidge et al., 2003). As disease variables do not fully account for the level of distress 
in children with JRDs (Cohen, 1999; Frank et al., 1998), it is necessary to further 
examine other variables which may play a role in adjustment. The cognitive appraisal 
variable of illness uncertainty has been consistently associated with psychological 
distress in chronically ill children (Hoff et al., 2002; Mullins et al., 1997; Neville, 1998). 
It is a variable that is uniquely appropriate for understanding the impact of the 
unpredictability of JRD flare-ups (e.g. changes in pain, joint mobility). A previous study 
which examined the impact of illness uncertainty on children with JRDs found parental 
distress (GSI) had a main effect on child depressive symptoms (CDI). Also, they found 
an interaction effect of parental distress and child illness uncertainty (CUIS) which 
accounted for 6% of the variance between disease factors, demographics and the main 
effect (White et al., 2005). Additionally, they found no significant impact of child 
uncertainty (CUIS) on child depressive symptoms (CDI). Unfortunately, the study by 
White and colleagues is the only study to date which looks at the role of child illness 
uncertainty in JRD. Clearly, parental psychological functioning impacts the 
psychological adjustment of their chronically ill child (Friedman et al., 2004; Robinson et 
al., 2007; & Timko et al., 1992). Based on the transactional stress and coping model 
outlines previously, it is appropriate to further elucidate the association between parental 
adjustment and child adjustment to JRDs and build on the study previously completed by 
White and colleagues.   
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 Based on the current knowledge of parental and child illness uncertainty and 
adjustment to JRDs, the purpose of this study was twofold. It first examined the 
relationship of parental uncertainty to child uncertainty after controlling for disease and 
demographic variables. Second, it examined the possible moderating role of parental 
distress on the relationship between parental illness uncertainty and child illness 
uncertainty.  
Primary Hypotheses: 
Hypothesis 1: It was hypothesized that parental illness uncertainty (MUIS) would be 
significantly associated with child illness uncertainty (CUIS), after controlling for disease 
and demographic variables.  
Hypothesis 2: In line with the transactional stress and coping conceptualization of family 
adjustment, it was hypothesized that parental distress (BSI) would moderate the 
relationship between parent illness uncertainty (MUIS) and child illness uncertainty 
(CUIS). 
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CHAPTER IV 
 
 
FINDINGS 
Overview of analyses 
The following statistical procedures were conducted to address the specific 
hypotheses of this study. Descriptive statistics were first conducted to examine possible 
covariates.  
Hypothesis 1: It was hypothesized that parental illness uncertainty (MUIS) would 
be significantly associated with child illness uncertainty (CUIS), after controlling for 
disease and demographic variables. It was anticipated that parental illness uncertainty 
would contribute significant variance to child illness uncertainty beyond the influence of 
demographic and disease variables.  
Hypothesis 2: In line with the transactional stress and coping conceptualization of 
family adjustment, it was hypothesized that parental distress (BSI) would moderate the 
relationship between parent illness uncertainty (MUIS) and child illness uncertainty 
(CUIS). The existence of a moderator relationship between parental distress and illness 
uncertainty would require the interaction of parental distress (as measured by the BSI) 
and illness uncertainty to contribute incremental unique variance to child illness 
uncertainty, beyond the influence of the main effects of these variables. 
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Preliminary Analyses 
Preliminary analyses were run to rule out the possible effects of demographic 
variables and disease subtype on key variables. Several one-way multivariate analysis of 
variance (MANOVAs) were conducted to examine the potential effects of demographic 
variables and disease subtype on child illness uncertainty (CUIS). There were no 
significant differences of demographic variables on disease variables (physician-rated 
disease severity, physician-rated disability, JAFAR-P, and illness duration; all p’s > .05) 
or psychosocial variables (MUIS-C, CUIS, BSI; all p’s > .05).  Additionally, there was 
no effect of disease subtype on disease variables (physician-rated disease severity, 
physician-rated disability, JAFAR-P, and illness duration; all p’s > .05) or psychosocial 
variables (CUIS, MUIS-C, BSI, all p’s > .05). 
 An examination of the correlation matrix indicated that there was a significant 
positive partial correlation between parental illness uncertainty and parental 
psychological distress (pr = .36, p < .01). In addition, there was a significant positive 
correlation between child illness uncertainty and subjective physician-reported disease 
severity (pr = .26, p < .05). Subjective physician-reported functional disability was also 
positively correlated with subjective physician-reported disease severity (pr = .60, p < 
.01). The parents assessment of child daily functioning (JAFAR-P) was significantly 
positively correlated with subjective physician-reported functional disability (pr = .35, p 
< .01) and physician-reported disease severity (pr = .30, p < .05). Lastly, ethnicity was 
significantly negatively correlated with age (pr = -.34, p <. 05). 
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 Selection of Covariates 
              Demographic and disease variables were included as covariates based on 
theoretical rationale, preliminary findings, and findings in the extant literature (age, 
gender, ethnicity, physician rated functional severity, physician rated functional 
disability, JAFAR-P and illness duration). Disease and demographic variables were 
included in order to provide for a more conservative test of the hypothesized relationships 
among variables and to control for possible shared variance. While the relationship is not 
always consistent, child disease severity has been shown to impact parental health in the 
past, and it was thus included as a covariate in this study (e.g., Bruns et al., 2008). 
Primary Analyses 
Hypothesis 1: A hierarchical regression equation was constructed to test the 
hypothesis that parental illness uncertainty (as measured by MUIS-C) would contribute 
significant variance to child illness uncertainty (as measured by the CUIS). Demographic 
variables were entered on Step 1 and disease variables were entered on Step 2. Parental 
illness uncertainty (MUIS-C) was entered on Step 3. Results revealed no significant 
effect of MUIS-C on CUIS, F(1, 50) = 1.04, p = 0.42 (see Table 2).  
Hypothesis 2: It was also anticipated that parental distress (BSI) would act as a 
moderator in the relationship between parental illness uncertainty (MUIS-C) and child 
illness uncertainty (CUIS) and contribute unique variance to CUIS, beyond the main 
effects of these variables.  A hierarchical multiple regression equation was constructed in 
which demographic variables were entered on Step 1 and disease variables were entered 
on Step 2. Parent illness uncertainty (MUIS-C) and child illness uncertainty were then 
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centered to reduce multicolliniarity (Slinker, B.K., & Glantz, S., 2008). The main effects 
of parent psychological distress (BSI) and parental illness uncertainty (MUIS-C) were 
entered on Step 3. On Step 4, a Parent Distress X Parent Illness Uncertainty (BSI X 
MUIS-C) interaction term was entered. Results revealed no significant BSI X MUIS-C 
interaction (F change = 0.01, p = .48).  
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CHAPTER V 
 
 
CONCLUSION  
The present study examined the transactional nature of adjustment in children 
with juvenile rheumatic diseases and their parents. Two specific hypotheses were 
proposed: 1) parental illness uncertainty and child illness uncertainty would be 
significantly related to each other, and, 2) parental distress would moderate the 
relationship between parental and child illness uncertainty. Contrary to the hypotheses, 
hierarchical multiple regression analyses revealed that parental illness uncertainty was 
not significantly associated with child illness uncertainty after controlling for disease 
variables.  In addition, a second hierarchical regression analyses revealed that parental 
distress did not function as a moderator in the parent-child illness uncertainty 
relationship.  
It has been shown in numerous studies on child chronic illness that there is a 
transactional pattern of adjustment within the family of the ill child. However, results of 
this study were not consistent with Thompson’s transaction stress and coping model of 
adjustment (Thompson et al., 1992). A number of possible explanations exist for such 
findings. First, it is possible that the current study did not have enough power to 
demonstrate the effect of parental uncertainty on child uncertainty.  Second, it is also 
possible that there was not enough variability in our sample’s experience of illness  
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uncertainty to demonstrate an impact. Lastly, it may be that in the context of JRDs, 
illness uncertainty is a variable that does not directly impact child illness uncertainty and 
that some unmeasured construct is a mediator or moderator that exists in the relationship 
Although the non-significant findings do not lend support to a significant 
relationship between parent and child illness uncertainty the bivariate correlations did 
reveal a positive relationship between parent and child illness uncertainty. A post hoc 
power analysis conducted using G Power showed the power for the current study was .78 
when using a small effect size (Faul, Erdfelder, Buchner, & Lang, 2009). It is possible 
that parental illness uncertainty alone does not have a large enough effect on child illness 
uncertainty independent of other variables. Future studies would do well to target more 
restricted age groups and more specific (high versus low) illness uncertainty groups.  
Another possible explanation for these discrepant findings may be a function of 
what appears to be an average level of illness uncertainty expressed by parents (M = 
69.64, SD = 14.98). The level of illness uncertainty in the current study falls within the 
range of parental illness uncertainty reported by parents of children with cancer (M = 
80.05, SD = 14.94, Lin, Yeh, & Mishel, 2010, M = 60.20, SD = 14.50, Santacroce, 2002) 
and type 1 diabetes mellitus (M = 63.47, SD = 13.42, Carpentier et al., 2006). Though 
speculative, it is possible that higher levels of parental uncertainty are necessary in order 
to make a significant contribution to child illness uncertainty. However, these findings 
are somewhat consistent with the results from Mullins and colleagues (2007), who found 
that the parent’s perceived child vulnerability did not predict illness uncertainty in 
children with Type 1 diabetes or asthma, although it was significant for adolescents. In 
addition, in a study on pediatric transplant recipients, Steele and colleagues (2009) found 
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youth-reported illness uncertainty was not significantly associated with parent-reported 
internalizing symptoms after controlling for both demographic factors and parent 
uncertainty. They did, however, find youth uncertainty was related to overall parent 
psychosocial functioning.  Although this study examined both child and parent illness 
uncertainty, the impact of parent IU on child IU was not included in the analyses. Thus, 
research on the relationships between parent and child illness uncertainty and parent 
psychosocial functioning remains inconclusive, thus warranting future studies in these 
areas. 
As demonstrated in the present study, parental illness uncertainty was 
significantly related to psychological distress in parents of children with JRDs. Prior 
studies have also supported the link between parent illness uncertainty and psychological 
distress. Steele and colleagues (2009) showed a significant association between increased 
parental illness uncertainty and parent-reported psychological distress in parents of youth 
recipients of liver and kidney transplantations. Additionally, a literature review by 
Stewart & Mishel (2000) supported the association between illness uncertainty and 
psychological distress in parents of children with a chronic illness (Stewart & Mishel, 
2000). Importantly, Carpentier and colleagues (2006) found longitudinal psychological 
distress in parents of chronically ill children could be predicted by initial illness 
uncertainty above and beyond the variance attributed to child illness duration and initial 
parental psychological distress. While there is a growing body of literature on the 
relationship between illness uncertainty and psychological distress, further examination 
of uncertainty and distress in parents of children with JRDs is necessary. 
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Parental psychological distress, while related to parental illness uncertainty, did 
not act as a moderator in the relationship between parent and child uncertainty. While 
previous research has shown parental distress to be associated with poorer child 
adjustment in JRDs (Timko et al., 1992) and other chronic illnesses (e.g., Thompson, Gil, 
Keith, Gustafson, George, & Kinney, 1994), the results of this study suggest it may not 
be associated with the cognitive appraisal variable of child illness uncertainty. White and 
colleagues (2005) found an interaction effect of parental distress and child illness 
uncertainty (CUIS) which accounted for 6% of the variance between disease factors, 
demographics and child depression scores.  Thus, it is possible that parental 
psychological distress may impact upon similar distress mechanisms in children but not 
have an impact on their cognitive experience of unclear or unpredictable illness-related 
events (Mishel, 1990). Further examination of the parental distress-child outcome 
relationship is necessary to better understand the transactional nature of the family’s 
cognitive appraisal of chronic illness.  
Strengths and Limitations 
There are several strengths to the present study, including being theoretically- 
driven, and the use of both parent- and child-report measures of illness uncertainty. The 
majority of studies on child adjustment to chronic illness have used only parent report 
data (almost exclusively mother report). However, there are multiple weaknesses in the 
present study. The small sample size resulted in low power, which may have resulted in 
the inability to detect the effects of parental illness uncertainty and distress, and thus a 
type I error. Small sample size can be an inherent difficulty in conducting research with 
chronic illness groups and in the future a larger sample size would be beneficial. 
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Additionally, the results are correlational in nature and thus no causal conclusions can be 
made. Longitudinal research would be helpful in order to determine causality and the 
direction of the relationships. Lastly, the current research used a global severity index of 
psychological distress (BSI), a measure that has been previously utilized in assessing 
adjustment in parents of chronically ill children (Andrews et al., 2007; Canning, Harris, 
& Kelleher, 1996; Pai et al., 2006; Wagner et al., 2003; White et al., 2005). However, in 
the future it may be beneficial to use a measure that highlights more specific aspects of 
distress (e.g., depression, anxiety) to further determine any possible relationship to illness 
uncertainty. 
Clinical Implications and Future Research 
Previous research has demonstrated the effect of parental distress on child 
depression symptoms is enhanced when child illness uncertainty is high (White et al., 
2005). Clinically, it would still seem important to address issues related to illness 
uncertainty as parental illness uncertainty and parental-reported psychological distress are 
associated in the present study. Akikusa & Allen (2002) recommend four steps to 
improving education about JRDs: a separate educational session, exploration of 
patient/family beliefs and misconceptions about JRDs, selection of the least complex 
treatment regimen, and careful discussion about medications. Basic education about JRDs 
continues to be recommended and supported by the present findings. It would be 
beneficial to add this educational component to treatment and compare results to a 
treatment as usual group. In such an experimental design, the longitudinal relationship 
between parental and child illness uncertainty and parental and child distress could be 
examined with greater control.  
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The current study was the first to show a significant relationship between 
physician-rated disease severity and child illness uncertainty. As previous research on the 
impact of illness severity in other chronic diseases has been mixed (Bruns et al., 2008, 
Frank et al., 1998, Sawyer, Whitham, Roberton, Taplin, & Varni et al., 2004, Vandvik, 
Hoyeraal, & Fagertun, 1989), the present finding helps elucidate the impact of this 
disease factor on illness uncertainty in the JRD population. Early identification of those 
children with severe JRDs may be helpful in reducing illness uncertainty, which has been 
previously associated with poorer child psychological adjustment (Hoff et al., 2002, 
Mullins et al., 1997, Neville, 1998). Importantly, the majority of past research has 
focused on educational interventions for adults and parents (e.g., Carpentier et al., 2006, 
Gil et al., 2006, Holm et al., 2008, Hommel et al., 2003). While it continues to remain 
important to address parental illness uncertainty, the present study highlights the lack of a 
relationship between parental and child illness uncertainty. It appears that interventions 
aimed at reducing parent illness uncertainty will not directly impact child illness 
uncertainty. Future studies should take into consideration the unique nature of child 
illness uncertainty and specifically target this cognitive appraisal variable.  
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Table 1. Disease, demographic and psychosocial variables 
 
Variables   Frequency      M    %   SD 
 
Child’s Gender 
Male             20     33% 
Female              41     67% 
 
Child’s Ethnicity 
Caucasian             28     46%   
  
African American             6     10% 
Native American            16     26% 
Hispanic               6     10% 
Asian               1     1.5% 
Biracial                    4     6.5% 
 
Child’s Age (years)      14.42    (2.88) 
 
Diagnosis 
JRA               35     58% 
Lupus            14     23% 
JAS             4     6.5% 
JDMA                 7     11.5% 
 
Illness Duration (years)     2.12    (3.20)  
 
PR Functional Disability    1.53    (0.65) 
 
PF Functional Severity     3.19    (1.76) 
 
JAFAR-P      5.09    (6.67)  
 
BSI       1.97    (0.50) 
 
MUIS-C      69.64    (14.98) 
 
CUIS       68.05    (18.00)  
Note. PR = Physician-rated; JAFAR-P = Juvenile Arthritis Functional Assessment 
Report; BSI = Brief Symptom Inventory; MUIS-C: Illness Uncertainty, parent form; 
CUIS: Illness Uncertainty, child form 
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Table 2. Zero-order correlations for Study Variables 
Variables 1 2 3 4 5 6 7 8 9 10  
1. Age 
_          
 
2. Ethnicity 
-.34** _          
3. Gender 
.01 .02 -         
4.  Duration .03 .04 .04 _       
 
5. PRFD 
-.04 -.01 .02 -.03 _       
6.  PRDS 
-.09 .22 -.11 -.18 .60** _      
7. JAFAR-P 
.04 -.16 .09 .07 .35** .30* -     
8.  BSI 
.25 -.09 .06 .05 -.03 .07 .31* -    
9.  CUIS 
.03 .05 -.05 -.22 .01 .26* .03 -.07 _   
10.  MUIS-C 
.11 .12 .12 -.22 -.22 -.00 .13 .36** .18 _  
 
 
 PRDS = Physician-rated disease severity; JAFAR-C = Juvenile Arthritis Functional 
Assessment Report-Parent Form; PRFD = Physician-rated functional disability; Duration 
= Illness duration (in years); BSI = Brief Symptom Inventory; MUIS-C = Illness 
Uncertainty, parent form; CUIS: Illness Uncertainty, child form. Partial correlations, 
controlling for PRDS, JAFAR-P, PRFD, Duration, appear above the diagonal (in 
parentheses).         *p < .05.  **p < .01.   
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Table 3. Hierarchical Regression Analyses of Children’s Illness Uncertainty (CUIS) 
Step Variable β 
t for 
within-
step 
predictors 
R2 Change 
for step 
Cumulative 
R2 
F Change 
for step 
 
 
1 Gender -.05 -.05 .01 .01 .15 
 Age .06 .06    
 Ethnicity .08 .08    
2 PRDS .37 2.02 .12 .13 1.17 
 JAFAR-P -.01 .05    
 PRFD -.22 -1.28    
 Duration -.16 -1.01    
3 MUIS-C .04 .15 .01 .14 .40 
 BSI .10 .40    
4 BSI X MUIS-C -.76 -.71 .01 .15 .51 
 
Note:  PDRS = Physician-rated disease severity; JAFAR-P = Juvenile Arthritis 
Functional Assessment Report-Parent; PRFD = Physician-rated functional disability;  
Duration = Illness duration (in years); BSI = Brief Symptom Inventory; IIS-C = Illness 
Intrusiveness Scale-Child Form. 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX B 
 
INSTITUTIONAL REVIEW BOARD FORM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
 
 
 
 
 
 
 
 
 
 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX C 
 
CONSENT FORM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
I, ________________________ (name of participant’s parent/legal guardian), voluntarily consent to allow my child to 
participate in the investigation of psychological factors and juvenile rheumatic diseases (JRD). 
 
PURPOSE OF STUDY: The purpose of the study is to examine psychological factors associated with JRD disease 
processes. 
 
DESCRIPTION OF RESEARCH PROCEDURES: The research requires the completion of several paper-andpencil 
measures in the Pediatric Rheumatology Clinic at the Children’s Hospital of Oklahoma that address 
psychological factors and perceptions of life events, both in general and with respect to JRA. Some items on the 
questionnaires contain sensitive issues (e.g., depression, relationships, etc.). 
 
COST: There are no costs to your child for participating in this study. 
 
POSSIBLE RISKS: There is virtually no risk associated with completing questionnaires. It is possible that your child 
may experience some negative emotions during the completion of the questionnaires, but these will be short-lived and 
have no long-term effects. 
 
RIGHT TO REFUSE OR WITHDRAWAL: My child’s participation is voluntary; there is no penalty for refusal to 
participate, and my child is free to withdraw his/her consent and participation in this project at any time without 
penalty, after notifying the project director. 
 
BENEFITS: Although my child’s participation may not necessarily be personally beneficial to my child, the 
information derived from this project may have important implications for others who have JRD. The information 
gained may contribute to a better understanding of the cognitive/emotional functioning and overall treatment of 
individuals with JRD. 
 
COMPENSATION AND INJURY: I understand that my child and I will receive $10.00 compensation in the form of 
gift certificates for approximately one hour of participation, and there is no risk of injury as a result of this study. 
 
SUBJECT ASSURANCES: Any data collected as part of my child’s participation in this experiment will be treated as 
confidential and will received a code number so that they will remain confidential. In no case will any use be made of 
these data other than as research results. If data from my child’s participation is ever displayed, my child’s identity will 
remain confidential. 
I may contact Dr. John M. Chaney, Oklahoma State University, Psychology Department, 215 North Murray Hall, 
Stillwater, Oklahoma 74078, at (405) 744-5703 should I wish further information about the research. I may also contact 
the Institutional Review Board (IRB) executive assistant, Sharon Bacher, Oklahoma State University, 203 Whitehurst, 
Stillwater, Oklahoma 74078, (405) 744-5700. Should any problems arise during the course of the study I may take 
them to Dr. Maureen Sullivan, Psychological Department Head, Oklahoma State University, Department of 
Psychology, 215 North Murray Hall, Stillwater, Oklahoma, 74078, at (405) 744-6027. 
 
I have read and fully understand the consent form, and the option to receive a copy of this consent form has been give 
to me. I sign it freely and voluntarily. 
 
Date: _____________  Time: __________ (A.M./P.M.) 
 
Signed:________________________________________________ 
(Signature of participant’s parent/legal guardian) 
 
Witness(es) if required: __________________________________ 
 
I certify that I have personally explained all elements of this form to the subject before requesting the subject to sign it. 
 
Signed________________________________________________ 
(Project director or his/her authorized representative) 
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Assent Form 
 
By signing this form, you are saying that you volunteer to participate in the following study on 
feelings and juvenile rheumatoid disease (JRD). For this study you will complete several 
questionnaires. No harm will come to you as a result of participating in this study, however, you 
are free to stop at any time during your participation in the study. Although the information that 
you provide will not benefit you directly, other individuals with JRD and related medical 
conditions will likely benefit through better overall treatment of their disease. Your name will not 
be used after you complete these questionnaires. This means that the information you provide will 
not be made public in any way, and only you and the experimenter will know what answers you 
provide on the questionnaire. 
 
 
 
 
Signed: ______________________________________ 
(Signature of participant) 
 
 
Date: _______________  Time: ________________ (A.M./P.M.) 
 
 
Witness(es) if required: ____________________________________ 
 
 
I certify that I have explained all elements of this form to the participant before requesting them 
to sign it. 
 
Signed: _______________________________________ 
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Provider Questionnaire 
 
1. Patient’s Name_______________________________ 
 
2. Patient’s Diagnosis (if multiple diagnoses, please list rheumatic illness first; please 
indicate if patient is seropositive or ANA-positive): 
 
_____________________________________________________ 
_____________________________________________________ 
_____________________________________________________ 
 
 
3. When was the patient diagnosed with the above rheumatic illness? 
 
        Date of diagnosis: ________________ 
 
4. What is the patient’s current medication regimen? 
 
____________________________                         __________________________ 
____________________________                         __________________________ 
____________________________                         __________________________ 
____________________________                         __________________________ 
  
5. Currently, how active is the patient's illness? 
1          2       3          4       5      6       7 
      Not Active or         Mild          Moderate           Severe 
      In Remission 
 
6. Compared to other patients, how well does this patient adhere to his/her treatment? 
1          2       3          4       5      6       7 
      Adheres                Worse than      Better than          Adheres 
      Very Poorly          Most Patients             Most Patients                      Extremely 
                 Well 
7. Compared to the other patients, how well does this patient cope with his her illness? 
1          2       3          4       5      6       7 
      Copes                Worse than      Better than         Copes 
      Very Poorly          Most Patients             Most Patients                     Extremely 
                Well 
Based on the patient’s physical exam, please classify him/her into one of the following four 
classes 
Class I    Class II   Class III   Class IV 
Completely able to  Able to perform  Able to perform  Limited ability to 
perform usual   usual self-care and  usual self-care   perform usual 
activities of daily  vocational   activities, but   self-care, 
living, (self care,  activities, but   limited in   vocational and 
vocational, &  limited in   avocational  avocational 
avocational)  avocational  activities  activities 
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1. Age: _______ 
 
2. Gender:  M  F 
1  2 
 
3. Ethnicity:      1 Caucasian 
2 African American 
3 Native American 
4 Hispanic 
5 Asian 
6 Biracial; Specify: _______________ 
7 Other; Specify: _________________ 
 
4. Highest level of educational attained:   1 Elementary School 
2 Middle School 
3 High School 
4 Some College; Specify number of 
years:______________ 
5. Marital Status:  1 Never married 
2 Married 
3 Divorced 
4 Cohabitation (living with partner) 
5 Widowed 
6 Other: ________________ 
 
6. Parent’s Occupation:   Father:________________ Mother:_______________ 
 
7. Parent’s Highest level of education: 
 
Father   1  Middle School 
2  High School 
3  Some College; Specify number of years: _________ 
4  College Degree 
5  Post-Graduate Degree 
 
Mother  1  Middle School 
2  High School 
3  Some College; Specify number of years:_________ 
4  College Degree 
5  Post-Graduate Degree 
 
8. Living Arrangement: 1  Live alone 
2  Live with both parents 
3  Live with one parent; Specify with parent: ___________ 
4  Other; Specify: _________________________________ 
 
9. Are you currently taking any psychoactive medication (e.g., antidepressants, anti-anxiety)? 
Yes  No 
1  2 
 
10. Have you received any type of psychological counseling/therapy?  Yes  No 
78 
 
1  2 
 
11. Have you ever received counseling directly related to your JRD?  Yes  No 
1  2 
 
12. Please indicate the number of visits to your physician due to your JRD in the past 6 months: 
________ 
 
13. How severe do you think your JRD has been in the past year? 
1          2       3          4       5      6       7 
      Not Active or         Mild          Moderate           Severe 
      In Remission 
 
14. How much control do you think you have over the daily symptoms of your JRD? 
1           2        3           4   5       6                7 
      No Control        A Little Control      A Great Deal          Complete 
                  Of Control                         Control 
 
15. How much control do you think your physician has over the daily symptoms of your JRD? 
1           2        3           4   5       6                7 
      No Control        A Little Control      A Great Deal          Complete 
                  Of Control                         Control 
 
16. How much control do you think you have over the long-term course of your JRD? 
1           2        3           4   5       6                7 
      No Control        A Little Control      A Great Deal          Complete 
                  Of Control                         Control 
 
17. How much control do you think your physician has over the long-term course of your JRD? 
1           2        3           4   5       6                7 
      No Control        A Little Control      A Great Deal          Complete 
                  Of Control                         Control 
 
18. How important to you is the ability to perform, by yourself, activities of daily living such as 
dressing yourself? 
1           2        3           4   5       6                7 
      Not at all                A Little        Somewhat                    Very 
     Important             Important       Important        Important 
 
19. Currently, how active are the symptoms of your JRD? 
1           2        3           4   5       6                7 
       Not Active or          Mild            Moderate              Severe 
      In Remission 
 
20. Please indicate the number of school and/or work days you have missed in the past 6 months: 
________ 
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Scope and Method of Study: The present study attempted to examine the relationship 
between parent and child illness uncertainty, as well as the possible moderating 
variable of parental distress, in families with juvenile rheumatic diseases (JRD). 
Participants were 61(41 females; 20 males) children and adolescents between the 
ages of nine and 21 (M = 14.42; SD = 2.88) and their parents. Participants were 
recruited through the Pediatric Rheumatology Clinic at the University of 
Oklahoma Health Sciences Center in Oklahoma City, Oklahoma. The pediatric 
rheumatologist completed a Provider Questionnaire which included information 
regarding diagnosis duration, severity, and functional ability. Parents completed a 
background information questionnaire, the Brief Symptom Inventory (BSI, 
Derogatis & Melisaratos, 1983) and the Mishel Uncertainty in Illness Scale – 
Community Form (MUIS-C, Mishel & Braden, 1988). Children completed the 
Children’s Uncertainty in Illness Scale (CUIS, Mullins & Hartman, 1995).  
 
Findings and Conclusions: Results of the present study showed parental illness 
uncertainty was not related to child illness uncertainty. Additionally, while 
parental distress was related to parent illness uncertainty, it was not related to 
child illness uncertainty. Importantly, physician-rated illness severity was 
associated with child illness uncertainty. These findings suggest the need to 
examine different models for child illness uncertainty and parent illness 
uncertainty in JRDs, as no relationship was found between the two. Additionally, 
because child illness uncertainty was related to illness severity, clinical 
interventions should focus on providing educational interventions for children, as 
well as parents, especially those children with severe JRDs.  
 
